Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients
Gamucci, T., Moscetti, L., Mentuccia, L., Pizzuti, L., Mauri, M., Zampa, G., Pavese, I., Sperduti, I., Vaccaro, A., Vici, P.Volume:
140
Language:
english
Journal:
Journal of Cancer Research and Clinical Oncology
DOI:
10.1007/s00432-013-1556-4
Date:
February, 2014
File:
PDF, 287 KB
english, 2014